{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:42:49Z","timestamp":1793216569494,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Currently, endoscopic transsphenoidal surgery is the main treatment for pituitary neuroendocrine tumors (PitNETs). Excision of the tumor may have positive or negative effects on pituitary endocrine function, and the pituitary function of somatotroph tumors is a point of particular concern after the operation. This study aimed to conduct a meta-analysis on the effect of endoscopic transsphenoidal somatotroph tumor resection on pituitary function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic literature search was conducted for articles that included the evaluation of pituitary target gland before and after endoscopic transsphenoidal pituitary tumor resection and were published between 1992 and 2022 in PubMed, Cochrane, and Ovid MEDLINE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Sixty-eight studies that included biochemical remission rates in 4524 somatotroph tumors were concluded. According to the 2000 consensus, the biochemical remission rate after transsphenoidal endoscopic surgery was 66.4% (95%\n                      <jats:italic>CI<\/jats:italic>\n                      , 0.622\u20130.703;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.000), the biochemical remission rate was 56.2% according to the 2010 consensus (95%\n                      <jats:italic>CI<\/jats:italic>\n                      , 0.503\u20130.620;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.041), and with the rate of biochemical remission ranging from 30.0 to 91.7% with investigator\u2019s definition. After endoscopic resection, adrenal axis dysfunction was slightly higher than that before surgery, but the difference was not statistically significant. Hypothyroidism was 0.712 times higher risk than that before surgery (\n                      <jats:italic>OR<\/jats:italic>\n                      \u2009=\u20090.712; 95%\n                      <jats:italic>CI<\/jats:italic>\n                      , 0.527\u20130.961;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.027). Hypogonadism was 0.541 times higher risk than that before surgery (\n                      <jats:italic>OR<\/jats:italic>\n                      \u2009=\u20090.541; 95%\n                      <jats:italic>CI<\/jats:italic>\n                      , 0.393\u20130.746;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.000). Hyperprolactinemia was 0.131 times higher risk than that before surgery (\n                      <jats:italic>OR<\/jats:italic>\n                      \u2009=\u20090.131; 95%\n                      <jats:italic>CI<\/jats:italic>\n                      , 0.022\u20130.783;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.026). The incidence of pituitary insufficiency was 1.344 times the risk before surgery after endoscopic resection of somatotroph tumors, but the difference was not statistically significant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In patients with somatotroph tumors after undergoing endoscopic surgery, the risk of dysfunction and pituitary insufficiency tend to increase, while preoperative thyroid insufficiency, gonadal insufficiency, and hyperprolactinemia will be partially relieved.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12957-023-02958-2","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T01:04:04Z","timestamp":1677632644000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The effect of endoscopic transsphenoidal somatotroph tumors resection on pituitary hormones: systematic review and meta-analysis"],"prefix":"10.1186","volume":"21","author":[{"given":"Ding","family":"Nie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyue","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wakam","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songbai","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuzhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazhuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,1]]},"reference":[{"key":"2958_CR1","doi-asserted-by":"publisher","unstructured":"Lu L, et al. Classifying pituitary adenoma invasiveness based on radiological, surgical and histological features: a retrospective assessment of 903 cases. J Clin Med. 2022;11(9):2464. https:\/\/doi.org\/10.3390\/jcm11092464.","DOI":"10.3390\/jcm11092464"},{"key":"2958_CR2","doi-asserted-by":"publisher","first-page":"756855","DOI":"10.3389\/fendo.2022.756855","volume":"13","author":"JL Yan","year":"2022","unstructured":"Yan JL, et al. Surgical outcome and evaluation of strategies in the management of growth hormone-secreting pituitary adenomas after initial transsphenoidal pituitary adenectomy failure. Front Endocrinol (Lausanne). 2022;13:756855.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2958_CR3","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s11102-017-0790-1","volume":"20","author":"M Fleseriu","year":"2017","unstructured":"Fleseriu M, Gadelha M. Acromegaly, a pituitary special issue. Pituitary. 2017;20(1):2\u20133.","journal-title":"Pituitary"},{"issue":"6","key":"2958_CR4","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1177\/1932296820949882","volume":"15","author":"V Mercuri","year":"2021","unstructured":"Mercuri V, et al. Continuous glucose monitoring system in acromegalic patients: possible role in the assessment of glycemia control. J Diabetes Sci Technol. 2021;15(6):1346\u201351.","journal-title":"J Diabetes Sci Technol"},{"issue":"1","key":"2958_CR5","doi-asserted-by":"publisher","first-page":"30","DOI":"10.17925\/EE.2019.15.1.30","volume":"15","author":"EV Varlamov","year":"2019","unstructured":"Varlamov EV, McCartney S, Fleseriu M. Functioning pituitary adenomas - current treatment options and emerging medical therapies. Eur Endocrinol. 2019;15(1):30\u201340.","journal-title":"Eur Endocrinol"},{"issue":"6","key":"2958_CR6","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.3171\/2013.8.JNS13224","volume":"119","author":"DB Hazer","year":"2013","unstructured":"Hazer DB, et al. Treatment of acromegaly by endoscopic transsphenoidal surgery: surgical experience in 214 cases and cure rates according to current consensus criteri. J Neurosurg. 2013;119(6):1467\u201377.","journal-title":"J Neurosurg"},{"key":"2958_CR7","doi-asserted-by":"publisher","first-page":"807054","DOI":"10.3389\/fendo.2021.807054","volume":"12","author":"X Guo","year":"2021","unstructured":"Guo X, et al. Hyperprolactinemia and hypopituitarism in acromegaly and effect of pituitary surgery: long-term follow-up on 529 patients. Front Endocrinol (Lausanne). 2021;12:807054.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2958_CR8","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","volume":"33","author":"SL Asa","year":"2022","unstructured":"Asa SL, et al. Overview of the 2022 WHO classification of pituitary tumors. Endocr Pathol. 2022;33(1):6\u201326.","journal-title":"Endocr Pathol"},{"key":"2958_CR9","doi-asserted-by":"crossref","unstructured":"Akirov A, et al. The clinicopathological spectrum of acromegaly. J Clin Med, 2019. 8(11).","DOI":"10.3390\/jcm8111962"},{"issue":"6","key":"2958_CR10","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1530\/ERC-16-0106","volume":"23","author":"E Ritvonen","year":"2016","unstructured":"Ritvonen E, et al. Mortality in acromegaly: a 20-year follow-up study. Endocr Relat Cancer. 2016;23(6):469\u201380.","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"2958_CR11","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.mayocp.2021.11.007","volume":"97","author":"N Ershadinia","year":"2022","unstructured":"Ershadinia N, Tritos NA. Diagnosis and treatment of acromegaly: an update. Mayo Clin Proc. 2022;97(2):333\u201346.","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"2958_CR12","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3325\/cmj.2012.53.224","volume":"53","author":"A Mari\u0107","year":"2012","unstructured":"Mari\u0107 A, et al. Endocrinological outcomes of pure endoscopic transsphenoidal surgery: a Croatian Referral Pituitary Center experience. Croat Med J. 2012;53(3):224\u201333.","journal-title":"Croat Med J"},{"issue":"11","key":"2958_CR13","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1007\/s00701-017-3318-6","volume":"159","author":"C-J Chen","year":"2017","unstructured":"Chen C-J, et al. Microsurgical versus endoscopic transsphenoidal resection for acromegaly: a systematic review of outcomes and complications. Acta Neurochir. 2017;159(11):2193\u2013207.","journal-title":"Acta Neurochir"},{"issue":"9","key":"2958_CR14","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1210\/jc.2011-0554","volume":"96","author":"JA Jane Jr","year":"2011","unstructured":"Jane JA Jr, et al. Endoscopic transsphenoidal surgery for acromegaly: remission using modern criteria, complications, and predictors of outcome. J Clin Endocrinol Metab. 2011;96(9):2732\u201340.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2958_CR15","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1530\/eje.1.01863","volume":"152","author":"P Nomikos","year":"2005","unstructured":"Nomikos P, Buchfelder M, Fahlbusch R. The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical \u2018cure.\u2019 Eur J Endocrinol. 2005;152(3):379\u201387.","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2958_CR16","doi-asserted-by":"publisher","first-page":"E5","DOI":"10.3171\/2010.7.FOCUS10153","volume":"29","author":"PG Campbell","year":"2010","unstructured":"Campbell PG, et al. Outcomes after a purely endoscopic transsphenoidal resection of growth hormone-secreting pituitary adenomas. Neurosurg Focus. 2010;29(4):E5.","journal-title":"Neurosurg Focus"},{"issue":"3","key":"2958_CR17","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00701-004-0466-2","volume":"147","author":"R Trepp","year":"2005","unstructured":"Trepp R, et al. Treatment outcomes and mortality of 94 patients with acromegaly. Acta Neurochir (Wien). 2005;147(3):243\u201351 (discussion 250-1).","journal-title":"Acta Neurochir (Wien)"},{"issue":"3\u20134","key":"2958_CR18","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1159\/000095533","volume":"83","author":"DK Ludecke","year":"2006","unstructured":"Ludecke DK, Abe T. Transsphenoidal microsurgery for newly diagnosed acromegaly: a personal view after more than 1,000 operations. Neuroendocrinology. 2006;83(3\u20134):230\u20139.","journal-title":"Neuroendocrinology"},{"issue":"5","key":"2958_CR19","first-page":"1006","volume":"62","author":"AR Dehdashti","year":"2008","unstructured":"Dehdashti AR, et al. Pure endoscopic endonasal approach for pituitary adenomas: early surgical results in 200 patients and comparison with previous microsurgical series. Neurosurgery. 2008;62(5):1006\u201315 (discussion 1015-7).","journal-title":"Neurosurgery"},{"issue":"11","key":"2958_CR20","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1007\/s00701-017-3318-6","volume":"159","author":"CJ Chen","year":"2017","unstructured":"Chen CJ, et al. Microsurgical versus endoscopic transsphenoidal resection for acromegaly: a systematic review of outcomes and complications. Acta Neurochir (Wien). 2017;159(11):2193\u2013207.","journal-title":"Acta Neurochir (Wien)"},{"issue":"2","key":"2958_CR21","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s11102-012-0395-7","volume":"16","author":"CC van Bunderen","year":"2013","unstructured":"van Bunderen CC, et al. Predictors of endoscopic transsphenoidal surgery outcome in acromegaly: patient and tumor characteristics evaluated by magnetic resonance imaging. Pituitary. 2013;16(2):158\u201367.","journal-title":"Pituitary"},{"issue":"1","key":"2958_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2176\/nmc.49.1","volume":"49","author":"S Yano","year":"2009","unstructured":"Yano S, et al. Endoscopic endonasal transsphenoidal approach through the bilateral nostrils for pituitary adenomas. Neurol Med Chir (Tokyo). 2009;49(1):1\u20137.","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"1","key":"2958_CR23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3171\/2009.4.JNS09182","volume":"112","author":"S Ceylan","year":"2010","unstructured":"Ceylan S, Koc K, Anik I. Endoscopic endonasal transsphenoidal approach for pituitary adenomas invading the cavernous sinus. J Neurosurg. 2010;112(1):99\u2013107.","journal-title":"J Neurosurg"},{"issue":"4","key":"2958_CR24","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.neucir.2020.05.003","volume":"32","author":"JL G\u00f3mez-Amador","year":"2021","unstructured":"G\u00f3mez-Amador JL, et al. Endoscopic endonasal lateral transellar approach for growth hormone-secreting adenomas with cavernous sinus invasion: technical note and surgical results. Neurocirugia (Astur\u202f: Engl Ed). 2021;32(4):170\u20137.","journal-title":"Neurocirugia (Astur : Engl Ed)"},{"key":"2958_CR25","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.wneu.2017.08.182","volume":"108","author":"I Anik","year":"2017","unstructured":"Anik I, et al. Endoscopic transsphenoidal approach for acromegaly with remission rates in 401 patients: 2010 consensus criteria. World Neurosurg. 2017;108:278\u201390.","journal-title":"World Neurosurg"},{"issue":"2","key":"2958_CR26","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s11102-019-01020-3","volume":"23","author":"S Petersenn","year":"2020","unstructured":"Petersenn S, et al. Predictive factors for responses to primary medical treatment with lanreotide autogel 120 mg in acromegaly: post hoc analyses from the PRIMARYS study. Pituitary. 2020;23(2):171\u201381.","journal-title":"Pituitary"},{"key":"2958_CR27","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.clineuro.2014.09.004","volume":"126","author":"S Sarkar","year":"2014","unstructured":"Sarkar S, et al. Endocrinological outcomes following endoscopic and microscopic transsphenoidal surgery in 113 patients with acromegaly. Clin Neurol Neurosurg. 2014;126:190\u20135.","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"2958_CR28","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0889-8529(05)70058-X","volume":"28","author":"PU Freda","year":"1999","unstructured":"Freda PU, Post KD. Differential diagnosis of sellar masses. Endocrinol Metab Clin North Am. 1999;28(1):81\u2013117 (vi).","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"6","key":"2958_CR29","doi-asserted-by":"publisher","first-page":"E10","DOI":"10.3171\/2020.3.FOCUS2080","volume":"48","author":"T Cardinal","year":"2020","unstructured":"Cardinal T, et al. Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly. Neurosurgical Focus FOC. 2020;48(6):E10.","journal-title":"Neurosurgical Focus FOC"},{"key":"2958_CR30","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jocn.2021.05.058","volume":"90","author":"E Akkaya","year":"2021","unstructured":"Akkaya E, et al. T2-weighted magnetic resonance imaging as a novel predictor of surgical remission in newly diagnosed pituitary macroadenomas presenting as acromegaly. J Clin Neurosci. 2021;90:105\u201311.","journal-title":"J Clin Neurosci"},{"issue":"6","key":"2958_CR31","doi-asserted-by":"publisher","first-page":"E14","DOI":"10.3171\/2020.3.FOCUS2072","volume":"48","author":"M Hlav\u00e1\u010d","year":"2020","unstructured":"Hlav\u00e1\u010d M, et al. Ten years\u2019 experience with intraoperative MRI-assisted transsphenoidal pituitary surgery. Neurosurg Focus. 2020;48(6):E14.","journal-title":"Neurosurg Focus"},{"issue":"3","key":"2958_CR32","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s13760-020-01299-1","volume":"120","author":"L D'Angelo","year":"2020","unstructured":"D\u2019Angelo L, et al. Role of endoscopic surgical biopsy in diagnoses of intraventricular\/periventricular tumors: review of literature including a monocentric case series. Acta Neurol Belg. 2020;120(3):517\u201330.","journal-title":"Acta Neurol Belg"},{"key":"2958_CR33","doi-asserted-by":"publisher","first-page":"e1007","DOI":"10.1016\/j.wneu.2021.05.030","volume":"151","author":"A Goyal-Honavar","year":"2021","unstructured":"Goyal-Honavar A, et al. Impact of experience on outcomes after endoscopic transsphenoidal surgery for acromegaly. World Neurosurgery. 2021;151:e1007\u201315.","journal-title":"World Neurosurgery"},{"issue":"9","key":"2958_CR34","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1007\/s00701-013-1754-5","volume":"155","author":"S Ceylan","year":"2013","unstructured":"Ceylan S, et al. Endoscopic distinction between capsule and pseudocapsule of pituitary adenomas. Acta Neurochir (Wien). 2013;155(9):1611\u20139 (discussion 1619).","journal-title":"Acta Neurochir (Wien)"},{"key":"2958_CR35","doi-asserted-by":"publisher","unstructured":"Guo X, et al. Determinants of immediate and long-term remission after initial transsphenoidal surgery for acromegaly and outcome patterns during follow-up: a longitudinal study on 659 patients. J Neurosurg.\u00a02022;1\u201311. https:\/\/doi.org\/10.3171\/2021.11.JNS212137.","DOI":"10.3171\/2021.11.JNS212137"},{"issue":"1","key":"2958_CR36","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s40618-020-01296-4","volume":"44","author":"M Araujo-Castro","year":"2021","unstructured":"Araujo-Castro M, et al. Predictive model of surgical remission in acromegaly: age, presurgical GH levels and Knosp grade as the best predictors of surgical remission. J Endocrinol Invest. 2021;44(1):183\u201393.","journal-title":"J Endocrinol Invest"},{"key":"2958_CR37","doi-asserted-by":"publisher","first-page":"e259","DOI":"10.1016\/j.wneu.2018.06.009","volume":"117","author":"M Taghvaei","year":"2018","unstructured":"Taghvaei M, et al. Endoscopic endonasal approach to the growth hormone-secreting pituitary adenomas: endocrinologic outcome in 68 patients. World Neurosurg. 2018;117:e259\u201368.","journal-title":"World Neurosurg"},{"issue":"Supplement","key":"2958_CR38","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.4103\/0028-3886.287665","volume":"68","author":"BS Sharma","year":"2020","unstructured":"Sharma BS, Ranwa A, Garg K. Complication avoidance in endonasal endoscopic pituitary surgery. Neurol India. 2020;68(Supplement):S85-s91.","journal-title":"Neurol India"},{"issue":"5","key":"2958_CR39","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1590\/0004-282X20160042","volume":"74","author":"ER Constantino","year":"2016","unstructured":"Constantino ER, et al. Surgical outcomes of the endoscopic endonasal transsphenoidal approach for large and giant pituitary adenomas: institutional experience with special attention to approach-related complications. Arq Neuropsiquiatr. 2016;74(5):388\u201395.","journal-title":"Arq Neuropsiquiatr"},{"issue":"1","key":"2958_CR40","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s10143-021-01617-y","volume":"45","author":"M Castle-Kirszbaum","year":"2022","unstructured":"Castle-Kirszbaum M, et al. Predictors of visual and endocrine outcomes after endoscopic transsphenoidal surgery for pituitary adenomas. Neurosurg Rev. 2022;45(1):843\u201353.","journal-title":"Neurosurg Rev"},{"key":"2958_CR41","doi-asserted-by":"publisher","unstructured":"Stefanidis P, et al. Postoperative complications after endoscope-assisted transsphenoidal surgery for pituitary adenomas: a case series, systematic review, and meta-analysis of the literature. Hormones\u00a0(Athens, Greece). 2022;21(3):487-99. https:\/\/doi.org\/10.1007\/s42000-022-00362-1.","DOI":"10.1007\/s42000-022-00362-1"},{"issue":"6","key":"2958_CR42","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.jocn.2008.09.002","volume":"16","author":"P Charalampaki","year":"2009","unstructured":"Charalampaki P, et al. Surgical complications after endoscopic transsphenoidal pituitary surgery. J Clin Neurosci. 2009;16(6):786\u20139.","journal-title":"J Clin Neurosci"},{"issue":"1","key":"2958_CR43","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ecl.2007.10.011","volume":"37","author":"ME Molitch","year":"2008","unstructured":"Molitch ME. Nonfunctioning pituitary tumors and pituitary incidentalomas. Endocrinol Metab Clin North Am. 2008;37(1):151\u201371 (xi).","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"5","key":"2958_CR44","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1080\/17446651.2020.1800452","volume":"15","author":"K Abhinav","year":"2020","unstructured":"Abhinav K, et al. Managing complications of endoscopic transsphenoidal surgery in pituitary adenomas. Expert Rev Endocrinol Metab. 2020;15(5):311\u20139.","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"2","key":"2958_CR45","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3171\/2017.7.JNS171658","volume":"128","author":"DG Taylor","year":"2018","unstructured":"Taylor DG, Jane JA, Oldfield EH. Resection of pituitary macroadenomas via the pseudocapsule along the posterior tumor margin: a cohort study and technical note. J Neurosurg. 2018;128(2):422\u20138.","journal-title":"J Neurosurg"},{"issue":"2","key":"2958_CR46","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s11060-010-0247-0","volume":"101","author":"X Qu","year":"2011","unstructured":"Qu X, et al. The pseudocapsule surrounding a pituitary adenoma and its clinical significance. J Neurooncol. 2011;101(2):171\u20138.","journal-title":"J Neurooncol"},{"issue":"2","key":"2958_CR47","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.otc.2021.12.011","volume":"55","author":"J Vignolles-Jeong","year":"2022","unstructured":"Vignolles-Jeong J, et al. Complications in endoscopic pituitary surgery. Otolaryngol Clin North Am. 2022;55(2):431\u201348.","journal-title":"Otolaryngol Clin North Am"},{"key":"2958_CR48","unstructured":"Younus I, et al. Incidence and risk factors associated with reoperation for sellar hematoma following endoscopic transsphenoidal pituitary surgery. J Neurosurg. 2019;1\u20137."},{"issue":"4","key":"2958_CR49","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1227\/01.NEU.0000325725.77132.90","volume":"63","author":"N Fatemi","year":"2008","unstructured":"Fatemi N, et al. Pituitary hormonal loss and recovery after transsphenoidal adenoma removal. Neurosurgery. 2008;63(4):709\u201318 (discussion 718-9).","journal-title":"Neurosurgery"},{"issue":"4","key":"2958_CR50","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1111\/j.1365-2265.2008.03270.x","volume":"69","author":"CL Ronchi","year":"2008","unstructured":"Ronchi CL, et al. Long-term basal and dynamic evaluation of hypothalamic-pituitary-adrenal (HPA) axis in acromegalic patients. Clin Endocrinol (Oxf). 2008;69(4):608\u201312.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2958_CR51","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.nec.2019.05.009","volume":"30","author":"A Buttan","year":"2019","unstructured":"Buttan A, Mamelak AN. Endocrine outcomes after pituitary surgery. Neurosurg Clin N Am. 2019;30(4):491\u20138.","journal-title":"Neurosurg Clin N Am"},{"key":"2958_CR52","doi-asserted-by":"publisher","first-page":"807054","DOI":"10.3389\/fendo.2021.807054","volume":"12","author":"X Guo","year":"2022","unstructured":"Guo X, et al. Hyperprolactinemia and hypopituitarism in acromegaly and effect of pituitary surgery: long-term follow-up on 529 patients. Front Endocrinol. 2022;12:807054.","journal-title":"Front Endocrinol"},{"key":"2958_CR53","doi-asserted-by":"publisher","first-page":"e1043","DOI":"10.1016\/j.wneu.2021.01.019","volume":"149","author":"T Rahimli","year":"2021","unstructured":"Rahimli T, et al. Endoscopic endonasal approach to giant pituitary adenomas: surgical outcomes and review of the literature. World Neurosurg. 2021;149:e1043\u201355.","journal-title":"World Neurosurg"},{"issue":"2","key":"2958_CR54","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s11102-017-0854-2","volume":"21","author":"DL Penn","year":"2018","unstructured":"Penn DL, Burke WT, Laws ER. Management of non-functioning pituitary adenomas: surgery. Pituitary. 2018;21(2):145\u201353.","journal-title":"Pituitary"},{"issue":"2","key":"2958_CR55","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.otc.2021.12.008","volume":"55","author":"OY Tang","year":"2022","unstructured":"Tang OY, et al. Giant pituitary adenoma - special considerations. Otolaryngol Clin North Am. 2022;55(2):351\u201379.","journal-title":"Otolaryngol Clin North Am"},{"key":"2958_CR56","doi-asserted-by":"publisher","unstructured":"Ding Nie, Qiuyue Fang, Wakam Wong et al. The effect of endoscopic transsphenoidal somatotroph tumors resection on pituitary hormones: systematic review and meta-analysis, 26 July 2022, PREPRINT (Version 1) available at Research Square [https:\/\/doi.org\/10.21203\/rs.3.rs-1799913\/v1]","DOI":"10.21203\/rs.3.rs-1799913\/v1"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-023-02958-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-023-02958-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-023-02958-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T08:04:35Z","timestamp":1728979475000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-023-02958-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,1]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2958"],"URL":"https:\/\/doi.org\/10.1186\/s12957-023-02958-2","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,1]]},"assertion":[{"value":"6 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All authors consent to publish.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"71"}}